Paul Saladino Commercial Conflicts: Heart & Soil, Products, and Disclosure Rules

Credentials and commerce can share a homepage. Animal-based guidance that funnels intolerant users toward branded desiccated organs is not neutral nutrition education—it is a protocol–product bridge that deserves sunlight.

This article is informational and editorial only. It is not medical advice, diagnosis, or a treatment plan. Numbers and literature ranges cited here are not personal prescriptions. Consult a qualified clinician before changing medications, supplements, diet, equipment, or management of a diagnosed condition. Seek urgent care for emergencies.

Where do commercial incentives show up?

Desiccated organ lines commercialize nose-to-tail advice for people who will not cook liver.

Protocol pages can name honey, creatine, or organ products in example days—placement is data for COI analysis.

Podcasts, newsletters, and luxury retail create multi-channel funnels around identity diets.

What does COI change about claim grading?

Raises scrutiny on plant-harm maximalism and organ-capsule necessity when those claims sell alternatives to ordinary produce and ordinary food.

Does not erase heme iron, B12, or zinc density of animal foods—score composition separately from marketing cure lists.

Political or cultural cosplay amplifies reach; it is not a substitute for lipid trials.

How should consumers read product-shaped protocols?

Ask: would this advice stay identical if capsules did not exist? If not, you are reading a funnel.

Prefer whole-food experiments with lab monitoring over multi-SKU stacks sold as ancestral completeness.

Apply FDA raw-milk warnings regardless of smoothie aesthetics or celebrity adjacency.

What is the network editorial standard?

One-clause disclosure when commercial brands enter the frame; grade evidence after disclosure.

Symmetric COI hygiene for olive oil, supplements, devices, and meat brands alike.

Never launder safety claims through retail partnerships.

Sources: New Yorker meat diet feature 2023; Protocol page product mentions; FDA raw milk dangers.

Readers should dual-source primary literature, translate slogans into exposure units and effect sizes, and rank interventions by expected value under uncertainty. Cheap reversible steps often outrank extreme protocols. Opportunity cost is real: hours spent on unvalidated tests are hours not spent on sleep, training, protein adequacy, and primary care. Sex, life stage, comorbidities, medications, and geography change interpretation. Prefer falsifiable claims with named endpoints over multi-disease cure lists. Update beliefs when stronger trials appear rather than freezing identity around a single paper or influencer narrative. Measured curiosity beats both panic and complacency. Further reading should prioritize primary sources and consensus documents over secondary social summaries. When evidence is mixed, state both the signal and the limits in the same paragraph. When evidence is strong, still avoid overclaiming universality across populations.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.